NHMA Virtual Briefing Series on COVID-19: Session 8

Slides

Claim CME

To join as an NHMA Member, please visit our Membership Page.
If you have any questions, please contact us at [email protected].

Acknowledgment of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgment of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion 
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and National Hispanic Medical Association.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Amedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Objectives - After Attending This Program You Should Be Able To

1. To increase knowledge about the health disparity challenges facing Hispanics and access to COVID -19 treatment.
2. To present an overview of Monoclonal Antibody Treatment for COVID-19 including eligibility of patients, infusion therapy, outcomes, and adverse effects, and research.
3. To discuss strategies and lessons learned from physicians at a monoclonal antibody treatment site for Hispanics and other vulnerable populations.